Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial
Publisher:
Department of Neurology, Cork University Hospital,Date published:
20 February, 2002Region:
Republic of Ireland Publication type:
researchAlthough statins reduce coronary and cerebrovascular morbidity and mortality in middle-aged individuals, their efficacy and safety in elderly people is not fully established. Our aim was to test the benefits of pravastatin treatment in an elderly cohort of men and women with, or at high risk of developing, cardiovascular disease and stroke.
Similar entries
- Use of Statin Therapy to Reduce Cardiovascular Risk in Older Patients: Review
- Rosuvastatin to Prevent Heart Problems and Stroke in Persons 70 Years or Older
- Low dose aspirin and cognitive function in middle aged to elderly adults: randomised controlled trial
- Challenges facing anticoagulation among the elderly and frail
- Combined impact of lifestyle factors on mortality: prospective cohort study in US women
- Drug may reduce incidence of first cardiovascular event in older people
- Does low to moderate alcohol intake protect against cognitive decline in older people?
- Rosuvastatin for Primary Prevention in Older Persons With Elevated C-Reactive Protein...
- HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity
- Minimum amount of physical activity for reduced mortality and extended life expectancy: a prospective cohort study
